Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.
about
Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancerA comprehensive catalogue of somatic mutations from a human cancer genomeNuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer.E74-like factor inhibition induces reacquisition of hormone sensitiveness decreasing period circadian protein homolog 1 expression in prostate cancer cells.Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression.SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue.The transcription factor SPDEF suppresses prostate tumor metastasisIdentification of Post-Transcriptional Modulators of Breast Cancer Transcription Factor Activity Using MINDy.SAM-pointed domain ETS factor mediates epithelial cell-intrinsic innate immune signaling during airway mucous metaplasiaGenetics of melanomaPDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells.Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer.GADD45α and γ interaction with CDK11p58 regulates SPDEF protein stability and SPDEF-mediated effects on cancer cell migrationMaster regulators of FGFR2 signalling and breast cancer riskPDEF in prostate cancer.CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer.The androgen-induced protein AIbZIP facilitates proliferation of prostate cancer cells through downregulation of p21 expression.Prostate-derived Ets factor, an oncogenic driver in breast cancer.Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.SAM pointed domain ETS factor (SPDEF) regulates terminal differentiation and maturation of intestinal goblet cells.SPDEF: a molecular switch for E-cadherin expression that promotes prostate cancer metastasis.Gene signature driving invasive mucinous adenocarcinoma of the lung.High-throughput sequencing of the melanoma genome.
P2860
Q24306191-88147A0B-0BAD-46DA-BC35-F39B9651E377Q24628532-69E1E891-672D-4A70-9C03-E9B9DAFEC40CQ30156863-17C96879-601B-406E-95EB-C19EB400F63DQ30371371-24AAE705-A699-4285-A231-68DD62E0428BQ33567270-248EB667-C4AA-4214-83BF-B03FFC5B94B6Q33688960-C6F511BE-BB30-4B3C-BF6F-2B8EA54BF63DQ33799676-E1C48C4A-FF55-4094-A3FF-61309CD565E6Q34257025-55D48B6C-BEEF-4922-80D4-25848CD10779Q35082366-48F94EB5-B905-440A-905D-FEFE39038B5DQ35758944-7D740F13-F457-47F6-8DBD-17FDB7350016Q36215965-FBCF489A-DF0D-4024-BAA0-32922C53E066Q36229602-A8FC2C56-03A0-42EF-8090-87170114F767Q36339871-8504A843-91B8-4454-9498-B2306C6D1233Q36563659-B8C97B00-8708-4F8B-AB84-C10D6F4BEF4EQ37011750-52416691-81F3-4D8F-92A2-8541272D3591Q37038409-04FC7A27-BA44-419C-9D70-CDA7E68AA7E9Q37046475-81000F6E-B278-418D-BB7C-AF2C6DD2EB9DQ37186448-B2A6360E-FB0D-4A0A-9306-5D3ADF165A37Q37907174-28DFF4D9-A50A-4336-AB1D-FC19294120B0Q38719045-4A449B95-2EA4-4068-93B5-9A8821DE8658Q39182146-5B4487A3-51DE-454B-9BF7-529EA0B7211BQ39281243-9A522B82-9A7E-4C11-B8CC-37ED772BF20CQ39502702-CC3D93B8-E29B-4126-B52D-27C496747B28Q39692770-68597F36-C141-4D39-B3FA-4F1CBB8B6C70Q39794269-C7C013D9-4B4E-4735-B2C4-F0091AA0B28BQ41833246-236EC0DD-1BA7-44C3-960E-A7873F144BA3Q42293061-0107B726-255C-4B29-9899-8AC17B953BC8Q42773490-3180FDE6-6951-4918-88C1-84216E9C8BF0
P2860
Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Expression characteristics of ...... d prostate cancer progression.
@ast
Expression characteristics of ...... d prostate cancer progression.
@en
type
label
Expression characteristics of ...... d prostate cancer progression.
@ast
Expression characteristics of ...... d prostate cancer progression.
@en
prefLabel
Expression characteristics of ...... d prostate cancer progression.
@ast
Expression characteristics of ...... d prostate cancer progression.
@en
P2093
P2860
P1433
P1476
Expression characteristics of ...... d prostate cancer progression.
@en
P2093
Ashwani K Sood
Chalong Cheewakriangkrai
Chitta S Kasyapa
Jeff Groth
Joseph Geradts
Kerry J Rodabaugh
Mohamed M Desouki
Rakhee Saxena
P2860
P304
P356
10.1016/J.HUMPATH.2007.03.010
P407
P577
2007-05-22T00:00:00Z